Drug Patents owned by Avanir Pharms

1. Drug name - NUEDEXTA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8227484 AVANIR PHARMS Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders Jul, 2023

(9 months from now)

US7659282 AVANIR PHARMS Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders Aug, 2026

(3 years from now)

Drugs and Companies using DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE ingredient

Treatment: Treatment of pseudobulbar affect

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
20MG;10MG CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.